Publication | Open Access
Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy
19
Citations
0
References
2019
Year
High-risk Endometrial CancerMedicinePathologyGynecologyMolecular ClassificationCancer GenomicsPortec-3 TrialCancer TreatmentOncologyGynecology OncologyCancer ResearchEndocrine-related Cancer
No additional data available for this publication yet. Check back later!